234 related articles for article (PubMed ID: 28156153)
21. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
22. Age-Dependent Clinicopathological Characteristics of Patients with T1b Papillary Thyroid Carcinoma: Implications for the Possibility of Active Surveillance.
Won HR; Jeon E; Heo DB; Chang JW; Shong M; Kim JR; Ko H; Kang YE; Yi HS; Lee JH; Joung KH; Kim JM; Lee Y; Kim SW; Jeong YJ; Ji YB; Tae K; Koo BS;
Ann Surg Oncol; 2023 Apr; 30(4):2246-2253. PubMed ID: 36581723
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma.
Park JP; Roh JL; Lee JH; Baek JH; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Am J Surg; 2014 Sep; 208(3):412-8. PubMed ID: 24602323
[TBL] [Abstract][Full Text] [Related]
24. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
25. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors.
Zheng W; Wang X; Rui Z; Wang Y; Meng Z; Wang R
Nucl Med Commun; 2019 May; 40(5):477-483. PubMed ID: 30973839
[TBL] [Abstract][Full Text] [Related]
27. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
[TBL] [Abstract][Full Text] [Related]
28. The influence of papillary thyroid microcarcinomas size on the occurrence of lymph node metastases.
Goran M; Markovic I; Buta M; Gavrilovic D; Cvetkovic A; Santrac N; Rakovic M; Milijic NM; Dzodic R
J BUON; 2019; 24(5):2120-2126. PubMed ID: 31786884
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients.
Kim KJ; Kim SM; Lee YS; Chung WY; Chang HS; Park CS
Ann Surg Oncol; 2015 Jan; 22(1):125-31. PubMed ID: 25092159
[TBL] [Abstract][Full Text] [Related]
30. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
32. Extent of lateral neck dissection for papillary thyroid microcarcinomas.
Lee JH; Chun YS; Chung YS
Head Neck; 2019 May; 41(5):1367-1371. PubMed ID: 30536753
[TBL] [Abstract][Full Text] [Related]
33. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma.
Sheng L; Shi J; Han B; Lv B; Li L; Chen B; Liu N; Cao Y; Turner AG; Zeng Q
Am J Surg; 2020 Aug; 220(2):334-340. PubMed ID: 31818425
[TBL] [Abstract][Full Text] [Related]
34. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
[TBL] [Abstract][Full Text] [Related]
35. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
36. ANALYSIS OF POSTOPERATIVE ULTRASONOGRAPHY SURVEILLANCE AFTER HEMITHYROIDECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A MULTICENTER STUDY.
Baek HJ; Kim DW; Lee CY; Huh JY; Sung JY; Choi YJ
Endocr Pract; 2017 Jul; 23(7):794-802. PubMed ID: 28448763
[TBL] [Abstract][Full Text] [Related]
37. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
38. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
[TBL] [Abstract][Full Text] [Related]
39. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
[TBL] [Abstract][Full Text] [Related]
40. Is multifocality a risk factor in low-risk papillary thyroid cancer?
Sapuppo G; Grasso S; Di Benedetto G; Marturano I; Costanzo G; Belfiore A; Pellegriti G
Endokrynol Pol; 2022; 73(6):928-934. PubMed ID: 36094871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
